Delivery Order SPE2DE21D0005-SPE2D625F8V7C

Award Date 5/21/25
Potential Completion Date 5/27/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,239.95 fixed-price delivery order awarded to Organogenesis Inc., a leading regenerative medicine company, by the Defense Logistics Agency Troop Support Medical (DLA Troop Support). The award is for APLIGRAF, a wound care product provided under contract SPE2DE21D0005|SPE2D624F1W56 with a completion date of March 21, 2024. Organogenesis Inc. has been awarded numerous prime federal contracts to provide wound care dressings, surgical implants, tissue regeneration products, and other...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Organogenesis Inc., a for-profit manufacturer of advanced regenerative medicine products. The $1,239.95 fixed-price contract is for the supply of the APLIGRAF wound care product, with a period of performance through November 1, 2024. Organogenesis is an established federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract is for the supply of the company's APLIGRAF product, a specialized skin substitute used in medical treatments. The $1,239.95 fixed-price contract with economic price adjustment has a completion date of November 13, 2024....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit medical device manufacturer based in Canton, Massachusetts. The contract, valued at $1,239.95, is for the provision of APLIGRAF, a skin substitute product used for advanced wound care. The contract does not have a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis has established itself as a key...
This is a fixed-price delivery order for $1,239.95 awarded to Organogenesis Inc. by the Defense Logistics Agency Troop Support Medical, which is part of the Department of Defense. The contract has an ultimate completion date of April 1, 2024 and provides for the delivery of APLIGRAF, a regenerative medicine product used for advanced wound care. Organogenesis Inc. is a leading manufacturer of regenerative medicine solutions and has been awarded numerous prime federal contracts to provide wound...
This is a $1,239.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company. The order is for the company's APLIGRAF product, which is a wound dressing and tissue regeneration solution. Organogenesis has been awarded numerous prime federal contracts by the DLA and Department of Veterans Affairs (VA) to provide advanced wound care and surgical products. This specific award is not associated with a set-aside program....
This $1,239.95 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Medical Supply Chain division of the Defense Logistics Agency. The order is for APLIGRAF, a wound care product, and has a completion date of March 20, 2024. Organogenesis previously held several large Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and Defense Logistics Agency to supply surgical implants, wound care matrices, and other tissue...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F8V7C
    Delivery Order

This is a $1,239.95 fixed-price delivery order contract awarded to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of the APLIGRAF skin substitute product, which is used for advanced wound care.

Organogenesis is a key supplier of medical products to federal healthcare agencies, including the Department of Veterans Affairs (VA) and the DLA, and has several significant federal contract vehicles in place, such as a $25 million Indefinite Delivery Contract with the VA for surgical implants, a $30 million Federal Supply Schedule contract, and a $49.5 million Indefinite Delivery Contract with the DLA for wound care products. This latest award does not utilize a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. The contract has a period of performance through May 27, 2025.

Generated 8/20/25, 9:50 AM